Cargando…

REAL-world evidence of risk factors and comorbidities in YOUNG Indian adults with type 2 diabetes mellitus: A REAL YOUNG (diabetes) study

OBJECTIVE: To assess the clinical characteristics, risk factors, and comorbidities associated with type 2 diabetes mellitus (T2DM) in young adult patients. METHODS: This is a retrospective, multicentric real-world study that included young adults (18–45 years) with T2DM. Primary information includin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saboo, Banshi, Agarwal, Sanjay, Gupta, Sunil, Makkar, Brij, Panneerselvam, A, Sahoo, Abhay Kumar, Ramchandani, G. D., Das, Sambit, Erande, Suhas, Kadam, Yogesh, Abhyankar, Mahesh V., Revankar, Santosh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565132/ https://www.ncbi.nlm.nih.gov/pubmed/34760771 http://dx.doi.org/10.4103/jfmpc.jfmpc_2010_20

Ejemplares similares

Risk Factors and Comorbidities in Young Indian Patients with Hypertension: REAL YOUNG (Hypertension) Study
por: Desai, Nagaraj, et al.
Publicado: (2021)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
por: Iyengar, S. S., et al.
Publicado: (2020)

RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus
por: Kumar, Vasanth, et al.
Publicado: (2022)

Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence
por: Sahay, Rakesh Kumar, et al.
Publicado: (2020)

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
por: Das, Sambit, et al.
Publicado: (2021)

Real-World Clinical Experience on the Usage of High-Dose Metformin (1500-2500 mg/day) in Type 2 Diabetes Management
por: Das, Ashok Kumar, et al.
Publicado: (2021)

Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study
por: Erande, Suhas, et al.
Publicado: (2023)

Evolving Scope of Clinical Empathy in the Current Era of Medical Practice
por: B, Jayakrishnan, et al.
Publicado: (2023)

Current Practices and Gaps in Management of Dyslipidemia in Type 2 Diabetes Mellitus (T2DM) in Accordance with American Diabetes Association (ADA) Guidelines: A Subset Analysis from a Real-World, Cross-Sectional Observational Study (LEADD Study)
por: Das, Ashok Kumar, et al.
Publicado: (2021)

RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
por: Chawla, Rajeev, et al.
Publicado: (2020)

RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
por: Chawla, Rajeev, et al.
Publicado: (2020)

Key elements of successful intensive therapy in patients with type 1 diabetes
por: Saboo, Banshi
Publicado: (2015)

Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Mellitus
por: Panneerselvam, P, et al.
Publicado: (2023)

RSSDI’s Defeat Diabetes Campaign: India takes a major leap in the direction of diabetes care capital of the world
por: Saboo, Banshi, et al.
Publicado: (2021)

Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2
por: Sosale, Bhavana, et al.
Publicado: (2016)

Management of anemia in patients with diabetic kidney disease: A consensus statement
por: Bajaj, Sarita, et al.
Publicado: (2016)

Knowledge, attitudes and practices towards COVID-19 among young adults with Type 1 Diabetes Mellitus amid the nationwide lockdown in India: A cross-sectional survey
por: Pal, Rimesh, et al.
Publicado: (2020)

Challenges and practice pattern of dyslipidaemia management in India during COVID-19 pandemic: A cross-sectional survey
por: Abhyankar, Mahesh V., et al.
Publicado: (2020)

Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidence
por: Sosale, Aravind, et al.
Publicado: (2015)

Limited Joint Mobility in Type 1 Diabetes: Diabetic Cheiroarthropathy, a Neglected Entity
por: Swain, Jayshree, et al.
Publicado: (2023)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Gujarat cohort of the A(1)chieve study
por: Saboo, Banshi, et al.
Publicado: (2013)

Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

Insights on Medical Nutrition Therapy for Type 2 Diabetes Mellitus: An Indian Perspective
por: Viswanathan, Vijay, et al.
Publicado: (2019)

Evaluating Glycemic Control in Patients of South Asian Origin With Type 2 Diabetes Using a Digital Therapeutic Platform: Analysis of Real-World Data
por: Krishnakumar, Arjun, et al.
Publicado: (2021)

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
por: Kesavadev, Jothydev, et al.
Publicado: (2015)

Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era
por: Shrivastava, Abhishek, et al.
Publicado: (2023)

The rule of two-thirds in diabetes epidemiology
por: Kalra, Sanjay, et al.
Publicado: (2017)

Real-World Observational Study of Glimepiride and Metformin Fixed-Dose Combination Along With Insulin in the Management of Type 2 Diabetes Mellitus: Indian Experience
por: Prasanna Kumar, KM, et al.
Publicado: (2021)

Characteristics and Prevalence of Latent Autoimmune Diabetes in Adults (LADA)
por: Brahmkshatriya, Priyanka P., et al.
Publicado: (2012)

Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver
por: Prasad, Rashmi B., et al.
Publicado: (2021)

Optimizing the treatment of newly diagnosed type 2 diabetes mellitus with combination of dipeptidyl peptidase-4 inhibitors and metformin: An expert opinion
por: Das, Ashok K., et al.
Publicado: (2021)

Are We Ignoring the Real Needs of the Young?
Publicado: (1967)

Perception and Assumptions of Young Waterpipe Smokers in Mumbai, India
por: Nimma, Vijayalaxmi, et al.
Publicado: (2022)

Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022)

Comorbidities increase COVID‐19 hospitalization in young people with type 1 diabetes
por: Mann, Elizabeth A., et al.
Publicado: (2022)

Real-World Clinical Experience of Rosuvastatin as a Lipid-Lowering Therapy for Primary and Secondary Prevention of Cardiovascular Events (REAL ROSE)
por: Mehta, Ashwani, et al.
Publicado: (2022)

SUN-LB048 Takayasu Arteritis in a Young Woman with Type 1 Diabetes
por: Laurenzano, Sarah, et al.
Publicado: (2019)

Time-in-range as a target in type 2 diabetes: An urgent need
por: Saboo, Banshi, et al.
Publicado: (2021)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the East India cohort of the A(1)chieve study
por: Sahoo, Abhay Kumar, et al.
Publicado: (2013)

Addressing the Inertia: A Holistic Approach to Diabetic Foot Evaluation
por: Swain, Jayshree, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s74fpshurdjt12ineth9e1a68a